{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:07:06Z","timestamp":1772006826417,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013117","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000}}],"reference-count":86,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013117.pub2","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T05:28:36Z","timestamp":1624944516000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ivermectin treatment in humans for reducing malaria transmission"],"prefix":"10.1002","volume":"2021","author":[{"given":"Dziedzom K","family":"de Souza","sequence":"additional","affiliation":[{"name":"Noguchi Memorial Institute for Medical Research, College of Health Sciences; University of Ghana; Accra Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bradley","sequence":"additional","affiliation":[{"name":"MRC International Statistics and Epidemiology Group; London School of Hygiene & Tropical Medicine; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemence","family":"Leyrat","sequence":"additional","affiliation":[{"name":"Medical Statistics Department; London School of Hygiene & Tropical Medicine; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A","family":"Boakye","sequence":"additional","affiliation":[{"name":"Noguchi Memorial Institute for Medical Research, College of Health Sciences; University of Ghana; Accra Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Okebe","sequence":"additional","affiliation":[{"name":"Department of International Public Health; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"10180","key":"10.1002\/14651858.CD013117.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial","volume":"393","author":"Foy","year":"2019","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0002|cit2","unstructured":"Foy BD Alout H Seaman JA Rao S Magalhaes T Wade M RIMDAMAL I de-identified data\u00a0 Data on file (as supplied 10 March 2020)\u00a0"},{"issue":"10203","key":"10.1002\/14651858.CD013117.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(19)32139-7","article-title":"Analysis of the RIMDAMAL trial - Authors' reply","volume":"394","author":"Foy","year":"2019","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0004|cit4","unstructured":"Repeat ivermectin mass drug administrations for control of malaria: a pilot safety and efficacy study clinicaltrials.gov\/show\/nct02509481"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/1475-2875-13-417","article-title":"Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments","volume":"13","author":"Meyers","year":"2014","journal-title":"Malaria Journal"},{"issue":"9097","key":"10.1002\/14651858.CD013117.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0140-6736(97)07081-5","article-title":"Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes","volume":"351","author":"Bockarie","year":"1998","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013117.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-3156.2009.02354-1.x","article-title":"Ivermectin effect on the survival of Anopheles gambiae","volume":"14","author":"Chaccour","year":"2009","journal-title":"Tropical Medicine and International Health"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/653208","article-title":"Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control","volume":"202","author":"Chaccour","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13071-015-0735-3","article-title":"Differential effect of human ivermectin treatment on blood feeding Anopheles gambiae and Culex quinquefasciatus","volume":"8","author":"Derua","year":"2015","journal-title":"Parasites & Vectors"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s13063-017-2196-9","article-title":"Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial","volume":"18","author":"Souza","year":"2017","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","article-title":"Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages","volume":"85","author":"Kobylinski","year":"2011","journal-title":"American Journal of Tropical Medicine and\u00a0Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12936-017-1923-8","article-title":"Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles","volume":"16","author":"Kobylinski","year":"2017","journal-title":"Malaria Journal"},{"issue":"3","key":"10.1002\/14651858.CD013117.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/trstmh\/trx025","article-title":"Incidental mosquitocidal effect of an ivermectin mass drug administration on Anopheles farauti conducted for scabies control in the Solomon Islands","volume":"111","author":"Kositz","year":"2017","journal-title":"Transactions of the Royal Society of Tropical Medicine and\u00a0Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12936-019-2988-3","article-title":"The effect of ivermectin\u00ae on fertility, fecundity and mortality of Anopheles arabiensis fed on treated men in Ethiopia","volume":"18","author":"Mekuriaw","year":"2019","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0015|cit15","unstructured":"Efficacy and safety of high-dose ivermectin for reducing malaria transmission: a dose finding study clinicaltrials.gov\/show\/nct02511353"},{"issue":"3","key":"10.1002\/14651858.CD013117.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cid\/ciu797","article-title":"Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial","volume":"60","author":"Ou\u00e9draogo","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD013117.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"e0006221","DOI":"10.1371\/journal.pntd.0006221","article-title":"Promising approach to reducing Malaria transmission by ivermectin: sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi","volume":"12","author":"Pinilla","year":"2018","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013117.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1473-3099(18)30163-4","article-title":"Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Smit","year":"2016","journal-title":"Lancet Infected Diseases"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0019|cit19","unstructured":"Insecticide resistance management in Burkina Faso and C\u00f4te d'Ivoire (REACT) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03074435"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0020|cit20","unstructured":"Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination (MASSIV) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03576313"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0021|cit21","unstructured":"Repeat Ivermectin Mass Drug Administrations for MALaria Control II (RIMDAMAL II) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03967054"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0022|cit22","unstructured":"Adjunctive Ivermectin Mass Drug Administration for Malaria Control (MATAMAL) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04844905"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0023|cit23","unstructured":"Prachumsri J A novel vector control measure to combat the spread of artemisinin resistance in the Greater Mekong Subregion https:\/\/federalreporter.nih.gov\/Projects\/Details\/?projectId=893768"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0024|cit24","unstructured":"Rabinovich R Chaccour C BOHEMIA - Broad One Health Endectocide-based Malaria Intervention in Africa www.isglobal.org\/en\/-\/bohemia"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/1475-2875-13-500","article-title":"The duration of\u00a0Plasmodium falciparum\u00a0infections","volume":"13","author":"Ashley","year":"2014","journal-title":"Malaria Journal"},{"issue":"7572","key":"10.1002\/14651858.CD013117.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/srep01300","article-title":"Implications of temperature variation for malaria parasite development across Africa","volume":"3","author":"Blanford","year":"2013","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1002\/14651858.CD013117.pub2-BIB0028|cit28","first-page":"833","article-title":"Asymptomatic malaria infections: detectability, transmissibility and public health relevance","volume":"12","author":"Bousema","year":"2014","journal-title":"Nature Reviews\u00a0Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD013117.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00034983.2001.11813662","article-title":"Relationships between the prevalence and intensity of Loa loa infection in the central province of Cameroon","volume":"95","author":"Boussinesq","year":"2001","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"10203","key":"10.1002\/14651858.CD013117.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(19)31663-0","article-title":"Analysis of the RIMDAMAL trial","volume":"394","author":"Bradley","year":"2019","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1002\/14651858.CD013117.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1017\/S0031182000006570","article-title":"Ivermectin: effectiveness in lymphatic filariasis","volume":"121","author":"Brown","year":"2000","journal-title":"Parasitology"},{"issue":"3","key":"10.1002\/14651858.CD013117.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.15.3.361","article-title":"Avermectins, new family of potent anthelmintic agents: producing organism and fermentation","volume":"15","author":"Burg","year":"1979","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12936-015-0691-6","article-title":"Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda","volume":"14","author":"Chaccour","year":"2015","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12936-017-1801-4","article-title":"Ivermectin to reduce malaria transmission. I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety","volume":"16","author":"Chaccour","year":"2017","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"pii: e16090","DOI":"10.7554\/eLife.16090","article-title":"The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa","volume":"5","author":"Churcher","year":"2016","journal-title":"eLife"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0036|cit36","doi-asserted-by":"crossref","DOI":"10.1079\/9780851993744.0000","volume-title":"The Biology of Mosquitoes. Development, Nutrition, and Reproduction","author":"Clements","year":"1992"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013117.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.actatropica.2010.08.009","article-title":"Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan\u00ae) monotherapy","volume":"120","author":"Cupp","year":"2011","journal-title":"Acta Tropica"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0038|cit38","unstructured":"Deeks JJ Higgins JP Altman DG (editors) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\u00a0"},{"issue":"6","key":"10.1002\/14651858.CD013117.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00637608","article-title":"The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution","volume":"35","author":"Edwards","year":"1988","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0040|cit40","unstructured":"Eldridge S Campbell M Campbell M Drahota A Giraudeau B Higgins J Revised Cochrane risk of bias tool for randomized trials (RoB 2.0): additional considerations for cluster-randomized trials Available from\u00a0https:\/\/sites.google.com\/site\/riskofbiastool\/welcome\/rob-2-0-tool"},{"issue":"2","key":"10.1002\/14651858.CD013117.pub2-BIB0041|cit41","first-page":"79","article-title":"Ivermectin uptake and distribution in the plasma and tissue of Sudanese and Mexican patients infected with Onchocerca volvulus","volume":"42","author":"Elkassaby","year":"1991","journal-title":"Tropical Medicine and Parasitology"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0042|cit42","volume-title":"Manson's Tropical Diseases","author":"Farrar","year":"2013"},{"issue":"10203","key":"10.1002\/14651858.CD013117.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(19)31139-0","article-title":"Malaria eradication within a generation: ambitious, achievable, and necessary","volume":"394","author":"Feachem","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD013117.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0035-9203(00)90211-6","article-title":"The potential of ivermectin to control the malaria vector Anopheles farauti","volume":"94","author":"Foley","year":"2000","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"9070","key":"10.1002\/14651858.CD013117.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0046|cit46","first-page":"42","article-title":"The pharmacokinetics and interactions of ivermectin in humans - a mini-review","volume":"10","author":"Gonz\u00e1lez Canga","year":"2008","journal-title":"American Association of Pharmaceutical Scientists Journal"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0047|cit47","unstructured":"GRADEpro Guideline Development Tool McMaster University (developed by Evidence Prime, Inc.) 2020"},{"issue":"2","key":"10.1002\/14651858.CD013117.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008152.pub5","article-title":"Primaquine or other 8-aminoquinolines\u00a0for reducing Plasmodium falciparum transmission","author":"Graves","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD013117.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(04)01043-6","article-title":"The global distribution and population at risk of malaria: past, present, and future","volume":"4","author":"Hay","year":"2004","journal-title":"Lancet Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD013117.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1740774516643498","article-title":"Generalized estimating equations in cluster randomized trials with a small number of clusters: review of practice and simulation study","volume":"13","author":"Huang","year":"2016","journal-title":"Clinical Trials (London, England)"},{"issue":"6","key":"10.1002\/14651858.CD013117.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1254\/fpj.122.527","article-title":"Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy","volume":"122","author":"Ikeda","year":"2003","journal-title":"Nihon Yakurigaku\u00a0Zasshi. Folia Pharmacologica Japonica"},{"issue":"2s","key":"10.1002\/14651858.CD013117.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.19-0620","article-title":"A roadmap for the development of ivermectin as a complementary malaria vector control tool","volume":"102","author":"Billingsley","year":"2020","journal-title":"American Journal of Tropical Medicine and\u00a0Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13063-016-1571-2","article-title":"Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study","volume":"17","author":"Kahan","year":"2016","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD013117.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1475-2875-13-330","article-title":"Characterizing, controlling and eliminating residual malaria transmission","volume":"13","author":"Killeen","year":"2014","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0056|cit56","first-page":"321\u201331","article-title":"Cluster randomized trials with a small number of clusters: which analyses should be used?","volume":"47","author":"Leyrat","year":"2017","journal-title":"International Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD013117.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1586\/eri.13.45","article-title":"The silent threat: asymptomatic parasitemia and malaria transmission","volume":"11","author":"Lindblade","year":"2013","journal-title":"Expert Review of Anti-infective Therapy"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2883-2-15","article-title":"Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis","volume":"2","author":"Makunde","year":"2003","journal-title":"Filaria Journal"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.141","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"Higgins","year":"2020","journal-title":"Research\u00a0Synthesis\u00a0Methods"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0060|cit60","unstructured":"Stromectol. FDA-approved package insert www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/050742s026lbl.pdf"},{"issue":"Pt 10","key":"10.1002\/14651858.CD013117.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1242\/jeb.118570","article-title":"Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae","volume":"218","author":"Meyers","year":"2015","journal-title":"Journal of Experimental Biology"},{"issue":"11","key":"10.1002\/14651858.CD013117.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.pt.2003.09.004","article-title":"Mass drug treatment for lymphatic filariasis and onchocerciasis","volume":"19","author":"Molyneux","year":"2003","journal-title":"Trends in Parasitology"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pmed.1000412","article-title":"Some lessons for the future from the Global Malaria Eradication Programme (1955-1969)","volume":"8","author":"N\u00e1jera","year":"2011","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","article-title":"Review of mass drug administration for malaria and its operational challenges","volume":"93","author":"Newby","year":"2015","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2214-109X(19)30453-X","article-title":"Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis","volume":"8","author":"Nicolas","year":"2020","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"e50036","DOI":"10.1371\/journal.pone.0050036","article-title":"Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso","volume":"8","author":"Ouedraogo","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1475-2875-10-183","article-title":"The influence of mosquito resting behaviour and associated microclimate for malaria risk","volume":"10","author":"Paaijmans","year":"2011","journal-title":"Malaria Journal"},{"issue":"12","key":"10.1002\/14651858.CD013117.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008846.pub2","article-title":"Mass drug administration for malaria","author":"Poirot","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2915.1997.tb00292.x","article-title":"Anopheles gambiae gonotrophic cycle duration, biting and exiting behaviour unaffected by permethrin-impregnated bednets in the Gambia","volume":"11","author":"Qui\u00f1ones","year":"1997","journal-title":"Medical and Veterinary Entomology"},{"issue":"1","key":"10.1002\/14651858.CD013117.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s13071-016-1787-8","article-title":"Multiple insecticide resistance in the major malaria vector Anopheles funestus in southern Ghana: implications for malaria control","volume":"9","author":"Riveron","year":"2016","journal-title":"Parasites & Vectors"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1475-2875-12-56","article-title":"Successful malaria elimination strategies require interventions that target changing vector behaviours","volume":"12","author":"Russell","year":"2013","journal-title":"Malaria Journal"},{"issue":"3","key":"10.1002\/14651858.CD013117.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007483.pub2","article-title":"Artemisinin-based combination therapy for treating uncomplicated malaria","author":"Sinclair","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013117.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(19)30633-4","article-title":"Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study","volume":"20","author":"Slater","year":"2020","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2875-13-125","article-title":"Biting by Anopheles funestus in broad daylight after use of long-lasting insecticidal nets: a new challenge to malaria elimination","volume":"13","author":"Sougoufara","year":"2014","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013117.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/eva.12144","article-title":"Reduced survival and reproductive success generates selection pressure for the dengue mosquito Aedes aegypti to evolve resistance against infection by the microsporidian parasite Vavraia culicis","volume":"7","author":"Sy","year":"2014","journal-title":"Evolutionary Applications"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1475-2875-9-365","article-title":"Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors","volume":"9","author":"Sylla","year":"2010","journal-title":"Malaria Journal"},{"issue":"3","key":"10.1002\/14651858.CD013117.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4269\/ajtmh.1990.43.229","article-title":"Mortality and infertility in adult mosquitoes after the ingestion of blood containing ivermectin","volume":"43","author":"Tesh","year":"1990","journal-title":"American Journal of Tropical Medicine and\u00a0Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD013117.pub2-BIB0079|cit79","first-page":"790","article-title":"Mosquito behavior change after distribution of bednets results in decreased protection against malaria exposure","volume":"215","author":"Thomsen","year":"2017","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0080|cit80","unstructured":"World Health Organization WHO preferred product characteristics: endectocide for malaria transmission control apps.who.int\/iris\/bitstream\/10665\/255694\/1\/WHO-HTM-GMP-2017.10-eng.pdf?ua=1"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0081|cit81","unstructured":"World Health Organziation Ivermectin for malaria transmission control: Technical consultation meeting report www.who.int\/malaria\/mpac\/mpac-sept2016-invermectin-session9.pdf?ua=1"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0082|cit82","unstructured":"World Health Organization World Malaria Report 2019 www.who.int\/malaria\/publications\/world-malaria-report-2019\/en\/"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0083|cit83","unstructured":"WHO Strategic Advisory Group on Malaria Eradication Malaria eradication: benefits, future scenarios and feasibility. Executive summary www.who.int\/publications-detail\/strategic-advisory-group-malaria-eradication-executive-summary"},{"key":"10.1002\/14651858.CD013117.pub2-BIB0084|cit84","unstructured":"World Health Organization World Malaria Report 2020 www.who.int\/malaria\/publications\/i\/item\/9789240015791"},{"issue":"48","key":"10.1002\/14651858.CD013117.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"40232","DOI":"10.1074\/jbc.R112.406280","article-title":"Glutamate-gated chloride channels","volume":"287","author":"Wolstenholme","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"10.1002\/14651858.CD013117.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013117","article-title":"Ivermectin treatment in humans for reducing malaria transmission","author":"Souza","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:33:44Z","timestamp":1760135624000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013117.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":86,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013117.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}